The release of cell-free DNA from dying fat cells may contribute to obesity-linked tissue inflammation and metabolic dysfunction, a new study in mice suggests. The findings help to explain why obese individuals tend to suffer from chronic inflammation, and point to a specific protein called TLR9 as a possible therapeutic target. Chronic inflammation is a hallmark of obesity and obesity-related complications such as insulin resistance, yet the underlying mechanism remains largely unknown.
The release of cell-free DNA from degenerating fat tissue cells called adipocytes may contribute to obesity-linked inflammation, Sachiko Nishimoto et al. now show. In mice that were fed a high-fat diet for twelve weeks, the authors observed increased expression of the TLR9 protein in adipose tissue, as well as higher levels of circulating cell-free DNA.
Taking a closer look, the authors determin ed that macrophages, a key player in adipose tissue inflammation, express TLR9, adding further evidence of the protein’s role in inflammation. Treating the mice with a TLR9-inhibiting compound reduced the accumulation of macrophages in adipose tissue and improved insulin resistance. And analyzing human plasma samples, the authors found that circulating cell-free DNA positively correlated with obesity and insulin resistance in patients. The results hint that circulating cell-free DNA released by obesity-triggered adipocyte degeneration plays a causal role in the development of tissue inflammation.
Article: Obesity-induced DNA released from adipocytes stimulates chronic adipose tissue inflammation and insulin resistance, Sachiko Nishimoto, Daiju Fukuda, Yasutomi Higashikuni, Kimie Tanaka, Yoichiro Hirata, Chie Murata, Joo-ri Kim-Kaneyama, Fukiko Sato, Masahiro Bando, Shusuke Yagi, Takeshi Soeki, Tetsuya Hayashi, Issei Imoto, Hiroshi Sakaue, Michio Shimabukuro and Masataka Sata, Science Advances, doi: 10.1126/sciadv.1501332, published 25 March 2016.
Contact our news editors
For any corrections of factual information, or to contact our editorial team, please see our contact page.
Copyright Medical News Today: Excluding email/sharing services explicitly offered on this website, material published on Medical News Today may not be reproduced, or distributed without the prior written permission of Medilexicon International Ltd. Please contact us for further details.